联合用药和给药剂量的干预对注射剂安全性的影响

The effect of drug combination and drug dosage intervention on the safety of injection

目的:探讨联合用药和给药剂量的干预对注射剂安全性的影响,从而为后期临床合理用药提供一定的指导意义.方法:选取我院2014-05/2015-05收治的60例患者,将其随机分为干预组(n=30)与非干预组(n=30),实施健康教育、用药标准及监督检查工作等措施对其进行干预.结果:注射剂在临床应用过程中,经过对给药剂量及联合用药因素进行干预后,干预组患者的临床不良反应发生率明显低于非干预组患者.另外,干预组患者的临床用药费用及住院费用均较非干预组患者低.结论:联合用药及给药剂量的干预使应用注射剂的不良反应发生率明显降低.

AIM： To investigate the effect of drug combination and drug dosage intervention on the safety of injection,so as to provide some guidance for clinical rational drug use. METHODS： A total of 60 patients admitted into our hospital from May2014 to May 2015 were randomly divided into the intervention group（ n = 30） and the non-intervention group（ n = 30）. Health education,drug standards and supervision and inspection and other measures should be done to intervene. RESULTS： Through the drug combination and drug dosage intervention in clinical application,the occurrence of adverse reaction of the intervention group was significantly lower than that of the non-intervention group. In addition,costs of clinical medication and hospitalization in the intervention group were also lower than that of the non intervention group. CONCLUSION： The occurrence of adverse reaction after injection is significantly decreased with drug combination and drug dosage intervention.